Effect of Atorvastatin as a Renal Protection in Patients With Systemic Inflammatory Response Syndrome Using Renal Arterial Resistive Index
Condition: Renal Protection Interventions: Drug: Atorvastatin 40 Mg Oral Tablet; Drug: placebo drug Sponsor: Minia University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2023 Category: Research Source Type: clinical trials